Ray Dalio's ALAB Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 750,940 shares of Astera Labs, Inc. (ALAB) worth $82.3 M, representing 0.37% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 4 quarters.
Based on 13F filings, Ray Dalio has maintained this position in ALAB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 510,410 shares. Largest reduction occurred in Q3 2025, reducing 62,759 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Astera Labs (ALAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Astera Labs (ALAB) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +510,410 | Add 212.20% | 750,940 | $109.60 |
| Q4 2025 | +223,052 | Add 1276.19% | 240,530 | $166.36 |
| Q3 2025 | -62,759 | Reduce 78.22% | 17,478 | $195.80 |
| Q2 2025 | +80,237 | New Buy | 80,237 | $90.42 |
Ray Dalio's Astera Labs Investment FAQs
Ray Dalio first purchased Astera Labs, Inc. (ALAB) in Q2 2025, acquiring 80,237 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Astera Labs, Inc. (ALAB) for 4 quarters since Q2 2025.
Ray Dalio's largest addition to Astera Labs, Inc. (ALAB) was in Q1 2026, adding 750,940 shares worth $82.3 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 750,940 shares of Astera Labs, Inc. (ALAB), valued at approximately $82.3 M.
As of the Q1 2026 filing, Astera Labs, Inc. (ALAB) represents approximately 0.37% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Astera Labs, Inc. (ALAB) was 750,940 shares, as reported at the end of Q1 2026.